Medtronic Looking To Buy Smith & Nephew? Analysts Doubt It
This article was originally published in The Gray Sheet
Executive Summary
Medtronic may be looking to buy the British orthopedics device company in part so that it can move its home to the UK for tax purposes, according to a report from Bloomberg. But Securities analysts report that the rumored deal probably does not make sense for Medtronic.
You may also be interested in...
Medtronic Will Pay Edwards More Than $1 Billion To Settle TAVR Dispute
A settlement between the two companies dismissing all pending patent litigation related to transcatheter valve replacement technologies ends years of legal wrangling and ensures that the U.S. TAVR market will have at least two competitors.
New Ortho Juggernaut: Zimmer Acquires Biomet For $13.35 Billion
Zimmer has agreed to buy Biomet by the first quarter of 2015, furthering the trend of consolidation in the $45 billion orthopedic device industry. The companies had combined revenues of $7.8 billion in 2013.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”